Related references
Note: Only part of the references are listed.PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer
Tao Liu et al.
ONCOLOGY REPORTS (2017)
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
Shigeo Ohba et al.
CANCER RESEARCH (2016)
NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells
Cheng Zeng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer
Michael I. Koukourakis et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2016)
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells
H. Bhanot et al.
LEUKEMIA (2015)
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer
Jun Osugi et al.
LUNG CANCER (2015)
Acid Gradient across Plasma Membrane Can Drive Phosphate Bond Synthesis in Cancer Cells: Acidic Tumor Milieu as a Potential Energy Source
Gautam Dhar et al.
PLOS ONE (2015)
Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells
Kartik N. Rajagopalan et al.
CANCER & METABOLISM (2015)
Monocarboxylate Transporters 1-4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Marte Eilertsen et al.
PLOS ONE (2014)
Separation of metabolic supply and demand: aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane
Tamir Epstein et al.
CANCER & METABOLISM (2014)
Hypoxia upregulates the gene expression of mitochondrial aconitase in prostate carcinoma cells
Ke-Hung Tsui et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells
Hiroto Izumi et al.
CANCER SCIENCE (2011)
Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy
Michael I. Koukourakis et al.
CLINICAL CANCER RESEARCH (2011)
Cancer-associated IDH mutations: biomarker and therapeutic opportunities
K. E. Yen et al.
ONCOGENE (2010)
Lactate Dehydrogenase 5 Expression in Squamous Cell Head and Neck Cancer Relates to Prognosis following Radical or Postoperative Radiotherapy
Michael I. Koukourakis et al.
ONCOLOGY (2009)
Lactate dehydrogenase 5 expression in operable colorectal cancer: Strong association with survival and activated vascular endothelial growth factor pathway - A report of the tumour angiogenesis research group
Michael I. Koukourakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor microenvironmental physiology and its implications for radiation oncology
P Vaupel
SEMINARS IN RADIATION ONCOLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
MI Koukourakis et al.
BRITISH JOURNAL OF CANCER (2003)
Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung
K Minami et al.
LUNG CANCER (2002)
Share Paper
